Link Pharma Chem Limited (524748) Fair Value & Analysis
Other · IN · Market cap ₹101M
Fair value as of: Jul 4, 2026
From 21 valuation models · updated today
Share price −3.9% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹21.86 – ₹38.00 · fair‑value band ₹2.21 – ₹3.68 · the ₹26.99 price screens above the ₹2.94 fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Link Pharma Chem Limited (524748) currently trades at ₹26.99, while our model-based Fair Value estimate is ₹2.94 — implying the stock looks roughly 89.1% overvalued today. We read business quality at 51/100 (solid quality), in the Other sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Link Pharma Chem Limited generated revenue of ₹268M at a net margin of 4.6%. Revenue grew 27.4% year over year. It earns a return on equity of 10.9%. Net debt stands at ₹67.6M. Fundamentals as of Jul 4, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
About the company
Link Pharma Chem Limited manufactures and sells organic intermediates for pharmaceutical, agro, and specialty chemicals industries in India and internationally. It also engages in the custom synthesis/contract manufacturing for multistage synthesis for small, medium, and large companies. The company also exports its products. The company was incorporated in 1984 and is based in Vadodara, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Link Pharma Chem Limited reported revenue of ₹274M in FY2026 versus ₹536M in FY2022, a compound −15.4%/yr. Reported net income was ₹769K in FY2026, compounding −55.0%/yr from FY2022.
Is 524748 fairly valued? → Check now
Similar stocks
6 more Other stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| There MOH | €521.90 | €269.92 | -48% |
| Sony Corporation SON1 | €17.58 | €39.38 | +124% |
| Federal Home Loan Mortgage Corporation FREJO | $16.84 | $64.93 | +286% |
| 533278 533278 | ₹438.60 | ₹720.31 | +64% |
| Nestl?? India Limited 500790 | ₹1,459 | ₹279.60 | -81% |
| 540376 540376 | ₹3,993 | ₹1,806 | -55% |
Explore undervalued stocks
Frequently asked questions
Is Link Pharma Chem Limited (524748) undervalued?
What is the fair value of 524748?
What is the quality score of 524748?
What is the revenue of Link Pharma Chem Limited (524748)?
What is the net profit margin of 524748?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.